Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Optimizing Treatment Approaches and Evolution of HER2 Targeting in mCRC
Clinical Evolution of Targeted Treatments for HER2+ mCRC Patients
Saturday, July 2, 2022
14:10 – 14:25
Location: Rooms 115-116; Level 1
Session Speaker(s)
JS
Jonathan Strickler, MD
Supported by Seagen